BioCryst Pharmaceuticals
BCRX
#4609
Rank
S$2.18 B
Marketcap
$10.56
Share price
-0.49%
Change (1 day)
7.93%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : S$1.07 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is S$1.07 B. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31S$1.08 B9.64%
2022-12-31S$0.99 B24.24%
2021-12-31S$0.80 B116.51%
2020-12-31S$0.36 B224.61%
2019-12-31S$0.11 B35.16%
2018-12-31S$84.21 M15.07%
2017-12-31S$73.19 M-5.87%
2016-12-31S$77.75 M81.98%
2015-12-31S$42.72 M7.79%
2014-12-31S$39.63 M4.27%
2013-12-31S$38.01 M3.55%
2012-12-31S$36.71 M-5.51%
2011-12-31S$38.85 M
2000-12-31S$0.01 M
1997-12-31S$0.16 M-59.84%
1996-12-31S$0.41 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
S$0.96 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.78 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.95 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.30 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$30.41 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
S$3.1 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$27.92 B 2,508.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$1.12 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$15.8 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA